Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Lactated Ringer

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

Summary View

 

Lactated Ringer’s injection in aviva plastic container

Lactated Ringer’s in viaflex plastic container

Lactated Ringer’s and 5% Dextrose in viaflex plastic container

Sodium Lactate (M/6 sodium lactate) injections in viaflex plastic container

 

WARNINGS

  • Excessive administration of Sodium Lactate Injection, USP may result in hypokalemia

 

PRECAUTIONS

  • Do not connect flexible plastic containers in series in order to avoid air embolism due to possible residual air contained in the primary container
  • The osmolarity of Sodium Lactate Injection, USP is 334 mOsmol/L (calc). Administration of substantially hypertonic solutions may cause venous irritation, including phlebitis

 

ADVERSE REACTIONS

Class Reactions
  • Other manifestations of hypersensitivity/infusion reactions: decreased heart rate, tachycardia, blood pressure decreased.....
-
-